Interactions on record — worth a quick check against your medications. Based on 1 of 2 ingredients. Check your meds →
Dietary supplement

Ostagenin Max Ingredients & Drug Interactions

by EPG

Capsule Category: Non-nutrient/non-botanical
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

Ostagenin Max is a dietary supplement by EPG with 2 active ingredients. Its ingredients are commonly taken for muscle building, athletic performance, fat loss / body recomposition.Based on those ingredients, 611 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are (2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Ostagenin Max by EPG

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 2 of its 2 active ingredients.
  • No proprietary blends here — you can verify the dose of every single component.

Ostagenin Max contains 2 active ingredients: 5a-Hydroxy Laxogenin and ostarine (a selective androgen receptor modulator, or SARM). Ostarine is a research compound that's under investigation for muscle-wasting conditions and bone health.

The product also contains inactive ingredients — gelatin capsule material, magnesium stearate, and rice flour.

Does it work?

Not established
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not established

The graded evidence we hold for these ingredients covers different conditions than the ones this product is marketed for, so there's no established rating for its stated use — see Ostarine's own graded uses on its monograph.

Why this rating?
  • The label markets this product for: lean muscle gains and protein synthesis.
  • We looked for evidence on: Athletic performance, Cachexia, Muscular dystrophy, Sarcopenia, muscle strength, body composition — and 1 related terms.
  • The closest evidence on file: Ostarine is rated "Insufficient Reliable Evidence To Rate" for Athletic performance (Natural Medicines).
  • Also on file: Ostarine is rated "Insufficient Reliable Evidence To Rate" for Cachexia, Muscular dystrophy, Sarcopenia.

The evidence for ostarine isn't established in the data we hold. Studies have looked at it for athletic performance, cancer-related muscle loss (cachexia), muscular dystrophy, sarcopenia (age-related muscle loss), and breast cancer, but the reliable evidence is insufficient to rate how well it works for any of these.

We also don't have effectiveness data on file for 5a-Hydroxy Laxogenin.

The evidence, ingredient by ingredient Ostarine

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Ostarine carries serious safety concerns. It's an unapproved investigational drug — the FDA has not approved it for human use and has warned about supplements containing SARMs like ostarine because of documented safety risks.

The most common side effects reported in studies are stomach pain, loss of appetite, constipation, diarrhea, nausea, and temporary increases in liver enzymes (ALT). Liver damage (hepatotoxicity), though rare, has been documented.

In clinical trials, some people also experienced low red blood cells (anemia) and low platelets (thrombocytopenia). Because ostarine affects hormone pathways, the safety data advises against use during pregnancy and breastfeeding.

Side effects, ingredient by ingredient Ostarine

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Ostarine.
  • The most serious interaction on file is rated Moderate.
  • For scale: 612 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking Ostagenin Max, check with your pharmacist if you take any medications that damage the liver, any liver enzyme inhibitors or inducers (including rifampin and probenecid), or drugs that are metabolized by your liver's CYP3A4 or CYP2C9 systems. Ostarine interacts with a large number of medications — the checker on this page will help you identify your specific risks.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with no established evidence rating for its marketed use. Moderate medication interactions have been identified, and safety information is well characterized.

Ostagenin Max contains an unapproved research compound with documented liver and blood-related risks and no established effectiveness for any condition. If you're considering it, talk with your pharmacist or doctor first — especially if you take any medications or have liver concerns.

This is not a product to start without professional guidance.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 2 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Nov 21, 2018.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Ostagenin Max, straight from the product label.

Brand EPG
Net contents 60 Capsule(s)
Market status On market
Date entered into DSLD Nov 21, 2018
DSLD ID 182802
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses No Claim
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Ostagenin Max by EPG, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
2 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container
30
IngredientAmount% DV
5a-Hydroxy Laxogenin100 mg--
(2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide25 mg--

Other ingredients: Gelatin, Magnesium Stearate, Rice Flour

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formula

100 mg 5a-Hydroxy Laxogenin 25 mg Ostarin (MK-2866) (Per Serving)

General Statements

Increases Protein Synthesis 200% Enhance Natural Hormones Lean Muscle Gains Effective synergy of 2 great components

FDA Statement of Identity

Dietary Supplement

Suggested/Recommended/Usage/Directions

Suggested Use: Men: Take 2 capsules per day.

See for yourself

Ostagenin Max by EPG label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Ostagenin Max by EPG

These are the 2 active ingredients this product is made of. Select any to open its full monograph.

Serving size2 Capsule(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

5a-Hydroxy Laxogenin

100 mg per serving
25 mg per serving

Ostarine (also called MK-2866 or enobosarm) is an experimental, unapproved drug known as a SARM (selective androgen receptor modulator), not a true di...

(2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide monograph & interactions

Other (inactive) ingredients: Gelatin, Magnesium Stearate, Rice Flour. These complete the product’s ingredient list but are not active constituents.

Interaction report

Ostagenin Max by EPG Drug Interactions

Want to check YOUR meds against Ostagenin Max?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
611Drugs
440 Moderate 171 Minor

Each ingredient & the kinds of drugs it affects

For each ingredient in Ostagenin Max with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

(2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide6 drug types · 611 drugs

Cytochrome P450 3A4 (Cyp3A4) Inducers

Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Ostarine is partially metabolized by CYP3A4. Clinical research shows that taking rifampin, a potent inducer of CYP3A4, reduces the maximum plasma concentration of ostarine by 23% and the area under the curve by 43%.

Likelihood Possible Evidence B
Hepatotoxic Drugs

Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Some clinical research shows that ostarine can increase alanine aminotransferase, a marker of liver damage, in some patients. Additionally, the U.S. Food and Drug Administration warns that supplements containing SARMs, such as ostarine, have been associated with reports of liver toxicity and there are at least two reports of drug-induced liver injury attributed to the use of ostarine.

Likelihood Possible Evidence D
Probenecid (Benemid)

Theoretically, concomitant use of ostarine with probenecid could increase the effects and adverse effects of ostarine.
Clinical research shows that probenecid increases ostarine levels and slows the clearance of ostarine, likely via inhibition of UDP-glucuronosyltransferase (UGT). Ostarine is partially metabolized by UGT.

Likelihood Possible Evidence B
Rifampin (Rifadin)

Theoretically, concomitant use of ostarine with rifampin could decrease the clinical effects of ostarine.
Clinical research shows that taking rifampin with ostarine reduces the maximum plasma concentration of ostarine by 23% and the area under the curve by 43%. Ostarine is partially metabolized by cytochrome P450 3A4 (CYP3A4), and rifampin is a potent CYP3A4 inducer.

Likelihood Possible Evidence B
Cytochrome P450 2C9 (Cyp2C9) Substrates

Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Although in vitro research suggests that ostarine inhibits CYP2C9, more robust clinical research shows that ostarine does not significantly affect CYP2C9.

Likelihood Unlikely Evidence B
Cytochrome P450 3A4 (Cyp3A4) Inhibitors

Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Ostarine is partially metabolized by CYP3A4. However, clinical research shows that taking itraconazole, a potent inhibitor of CYP3A4, had minimal effects on the levels of ostarine in the body.

Likelihood Unlikely Evidence B
The maker

Brand information

Manufacturer and brand details for Ostagenin Max, from the product label.

EPG

See all EPG products
Name
Extreme Performance Group (EPG)
Pharmacist Counseling Corner

Ostagenin Max by EPG: Common Questions

Does Ostagenin Max by EPG interact with any medications?
Yes. Based on its ingredients, Ostagenin Max has a known interaction with 611 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Ostagenin Max contains 2 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Is Ostagenin Max approved by the FDA?
No. Ostarine, the active ingredient, is an unapproved investigational drug. The FDA has not approved it for human use and has specifically warned about supplements containing SARMs like ostarine because of documented safety risks.
What are the most common side effects?
Stomach pain, loss of appetite, constipation, diarrhea, and nausea are the most commonly reported. Some people also experience temporary increases in liver enzymes. Rare but serious side effects include liver damage and low blood cell counts.
Can I take this while pregnant or breastfeeding?
No. Ostarine affects hormone pathways and must be avoided during pregnancy. There is no safety data for breastfeeding, so it should be avoided then too. Talk with your doctor if you're pregnant, planning to become pregnant, or breastfeeding.
Does this product actually work for muscle building or athletic performance?
The reliable evidence to say whether it works for athletic performance, muscle loss, muscular dystrophy, or other conditions isn't established in our data. We also don't have effectiveness information on 5a-Hydroxy Laxogenin.
Why is there such a large number of medication interactions?
Ostarine is metabolized by several of your liver's enzyme systems (CYP3A4 and UGT), which means it interacts with many drugs that use those same pathways. Any medication that affects how your liver works can potentially change how ostarine behaves in your body.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Ostagenin Max is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Ostagenin Max label
Sources

Sources & How We Checked

Ostagenin Max's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 10 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Ostarine 10 references
  1. Warning Letter: Ironmag Labs 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582464.htm Accessed: November 1, 2017
  2. Warning Letter: Panther Sports Nutrition 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm581630.htm. Accessed: November 1, 2017
  3. Warning Letter: Infantry Labs LLC 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582685.htm. Accessed: November 1, 2017
  4. Dobs AS, Boccia RV, Croot CC, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol 2013;14(4):335-45. PubMed
  5. Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II tri
  6. Coss CC, Jones A, Dalton JT. Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024 (enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin. Invest New Drugs 2016;34(4):458-67. PubMed
  7. FDA. FDA Warns against using SARMs in body building products. October 2017. Available at: https://www.fda.gov/newsevents/newsroom/fdainbrief/ucm583021.htm.
  8. Bedi H, Hammond C, Sanders D, Yang HM, Yoshida EM. Drug-induced liver injury from enobosarm (ostarine), a selective androgen receptor modulator. ACG Case Rep J 2021;8(1):e00518. PubMed
  9. Kintz P, Gheddar L, Paradis C, et al. Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- d) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516
  10. Weinblatt D, Roy S. Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator. J Med Cases 2022;13(5):244-248. PubMed

See these in context on the Ostarine monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring